Facebook Tracking Image

National Comprehensive Cancer Network

Interactive CME

Educational Events & Programs


NCCN POLICY SUMMIT UPDATES  >  Click here for the article

On December 10, 2018, NCCN hosted a summit entitled, Patient Advocacy Summit: Advocating for Equity in Cancer Care. The summit provided an opportunity for a varied group of stakeholders including patients, patient advocacy organizations, industry, providers, and payers to thoughtfully discuss equitable patient access to high-quality oncology care and present best practices regarding how patient advocacy organizations can influence health care policy moving forward.

Prior to the summit, NCCN conducted an environmental scan that consisted of stakeholder meetings with patient advocates. The meetings examined current disparities in access, cost, and treatment in oncology, and identified policy strategies to address these significant barriers for patients with cancer.

An article was published in the Journal of the National Comprehensive Cancer Network―JNCCN.

Please check back often for additional updates regarding the summit. If you have any meeting content or agenda questions, please contact James McCanney, JD, Policy/Advocacy Fellow. For any media questions, please contact Rachel Darwin, Public Relations Manager.

Supported by Adaptive Biotechnologies. Supported by AmerisourceBergen. Supported by an educational donation provided by Amgen. Supported by Apobiologix, a division of ApoPharma USA, Inc. Supported by Astellas. Supported by AstraZeneca through its NCCN Corporate Council Membership. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. Supported by Celgene Corporation. Sponsored by Clovis Oncology, Inc. Sponsored by Dendreon. Supported by Eisai, Inc. Supported by EMD Serono. Supported by a non-restricted medical education grant from Gilead Sciences, Inc. Supported by HELSINN. Supported by Heron. Supported by Incyte Corporation. Supported by Janssen Pharmaceutical Companies of Johnson & Johnson. Supported by Juno Therapeutics. This activity is supported by a contribution from Lilly. Supported by an independent educational grant from Merck & Co., Inc. Sponsored by Novartis Pharmaceuticals Corporation. This activity was made possible by Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc. Supported by Regeneron. Sponsored by Sandoz, A Novartis Division. Supported by an unrestricted sponsorship from TESARO. Supported by Verastem. 

Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.